Hepatitis C treatment: recommendations 2016

The ITPCru team and SEVT Ltd. have developed a chart “Hepatitis C treatment: recommendations 2016″ which includes the recent recommendations for interferon-free treatment of HCV-monoinfected (EASL 2016) and HCV/HIV coinfected patients (EACS 2016). The chart also contains updated tables with all approved direct-acting antiviral drugs, as well as information about drug-drug interactions (HCV/HIV drugs).

The chart can be downloaded here:

Hepatitis C treatment – recommendations 2016

Original Article